Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

ANTIPARASYMPATHOMIMETIC EFFECTS OF CHOLINESTERASE INHIBITOR TREATMENT

Laszlo Z. Bito, Kelly Hyslop and John Hyndman
Journal of Pharmacology and Experimental Therapeutics July 1967, 157 (1) 159-169;
Laszlo Z. Bito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Hyslop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hyndman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Alterations in the pharmacologic properties of the iris of the cholinesterase inhibitor-treated eyes of the dog and rabbit have been investigated. One eye of each animal was treated with the cholinesterase inhibitor—in most cases, echothiophate iodide—three times daily for 10 to 18 days. After a few days of treatment the miotic (i.e., cholinergic) effectiveness of echothiophate gradually decreased until by the 5th day of treatment, it had virtually no miotic effect. These echothiophate-pretreated eyes also became refractory to the cholinergic effects of topically applied carbachol. Pilocarpine had a mydriatic rather than a miotic action on pretreated dog eyes. Cholinergic response could not be obtained in the echothiophate-pretreated rabbit eye even after intravitreal injection of 2000 times the normally effective dose of carbachol. In spite of these changes in its pharmacologic properties, the iris of the pretreated eye exhibited normal or, in the case of the dog, hyperactive physiologic responses to light. Atropine abolished these responses. These observations are discussed in the light of mechanisms known to control normal movements of the mammalian iris.

Footnotes

    • Received December 2, 1966.
    • Accepted January 25, 1967.
  • © 1967 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 157, Issue 1
1 Jul 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ANTIPARASYMPATHOMIMETIC EFFECTS OF CHOLINESTERASE INHIBITOR TREATMENT
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ANTIPARASYMPATHOMIMETIC EFFECTS OF CHOLINESTERASE INHIBITOR TREATMENT

Laszlo Z. Bito, Kelly Hyslop and John Hyndman
Journal of Pharmacology and Experimental Therapeutics July 1, 1967, 157 (1) 159-169;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ANTIPARASYMPATHOMIMETIC EFFECTS OF CHOLINESTERASE INHIBITOR TREATMENT

Laszlo Z. Bito, Kelly Hyslop and John Hyndman
Journal of Pharmacology and Experimental Therapeutics July 1, 1967, 157 (1) 159-169;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Pharmacological Characterization of Nicotine-Induced Seizures in Mice
  • Streptococcus pneumoniae Pneumonia in Mice: Optimal Amoxicillin Dosing Predicted from a Pharmacokinetic-Pharmacodynamic Model
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics